Xuefei H. Li
No. 507, Zheng Min Road
Shanghai, 200433, China
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 225 publications
Hydrogen-Bonded Organic Frameworks (HOFs) for C2 Gas Separation and Purification.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: July 13, 2026
Corrigendum to "Development and bioevaluation of 18F-labeled bivalent cyclic peptides for PET imaging of αvβ6 integrin overexpression" [Bioorganic Chem. 159 (2025) 108362].
Journal: Bioorganic chemistry
Published: March 09, 2026
Evaluation of preoperative plasma cytokines for the diagnosis and prognosis of malignant lung nodules.
Journal: Cancer treatment and research communications
Published: December 04, 2025
Stabilin-1+ lipid-associated macrophages promote lung adenocarcinoma liver metastasis and osimertinib resistance through impairing macrophage phagocytosis via SIRPα-CD47 axis.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: November 01, 2025
Head-to-head comparison of 18F-FAP-2286 PET/CT and 18F-FDG PET/CT in the diagnosis and staging of clear cell renal cell carcinoma: a prospective study.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 25, 2025
Purinergic signal transduction and metabolic regulation by ENTPD5 and ENTPD6.
Journal: Frontiers in endocrinology
Published: August 05, 2025
The pathogenesis and therapeutic management of rare pulmonary sarcomatoid carcinoma: a narrative review.
Journal: Translational lung cancer research
Published: July 31, 2025
Bispecific T-cell Engager (CD3 × EGFR)-Based Triplet Therapy Unlocks CD40/CD40L Crosstalk to Revert Immunosuppression in Third-Generation EGFR-Tyrosine Kinase Inhibitor-Refractory NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 04, 2025
A combined strategy of EGFR-MET bispecific antibody and HER3 ADC to overcome osimertinib resistance in NSCLC.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: May 19, 2025
Fibroblast activation Protein-Targeted PET/CT using [18 F]FAP-2286 for the evaluation of lung cancer: A comparative study with [18 F]FDG PET/CT.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 14, 2025
MS4A7 based metabolic gene signature as a prognostic predictor in lung adenocarcinoma.
Journal: Frontiers in molecular biosciences
Published: March 11, 2025
Corrigendum to "Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancer" [Eur J Cancer 189 (2023) 112919].
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 21, 2025
Last Updated: 09/26/2026